Close

Industry Reports

Zsquare Secures $10m for Its Groundbreaking 0.45mm Fiber, High-res, Single-use Imaging Endoscope

Zsquare, developer of the MultiPlyâ„¢ single-use endoscopic platform, has secured $10M in financing for further development of its revolutionary MultiPly Mini 0.45mm fiber endoscope, towards expedited FDA 510K clearance. This $10M round of new financing was led by Chartered Group,...

Gestalt Diagnostics Expands Market Reach and Solution Offerings with Peak Medical Acquisition

Gestalt Diagnostics announced that it has finalized the acquisition of laboratory integration services company Peak Medical. This strategic acquisition expands Gestalt's digital pathology integration services division and provides key industry expertise in healthcare connectivity services in addition to integration...

Global Health Care Leaders Back Aetion with $27 Million Strategic Investment

Aetion, the health care technology company that delivers the real-world analytics and evidence platform needed to engage in value-based care, announced it has attracted strategic investment from global leaders in biopharma and health care services, including Sanofi, UCB, McKesson...

Interventional Cardiology Devices Market globally expected to drive growth through 2025

Interventional cardiology deals with the treatment of the heart related diseases such as coronary artery disease, congenital heart defect and aneurysm through catheter based devices. The process involves the insertion of catheter into large peripheral artery or vein to...

Oxytocic Pharmaceuticals Market expected to increase at a CAGR of 9.7% in terms of revenues forecast period -2026

The global oxytocic pharmaceuticals market reached US$ 157.6 Mn in 2016. China, Asia Pacific excluding Japan and China (APEJC), and MEA collectively accounted for nearly 68.2% revenue share of the market in 2016. Surge in hospital based deliveries and...

Neuropathic Pain Market: lucrative opportunities and Fast Growth by 2026

According to a recent study conducted by RRI, the global market for neuropathic pain is expected to reflect a CAGR of over 5% during the forecast period (2016–2024). In 2015, the market was valued at over US$ 5 Billion...

Polycystic Ovary Syndrome Drugs Market to represent a significant expansion at 4.7% CAGR by 2024

Polycystic ovary disorder (PCOS) is a usual hormonal endocrine issue that influences women of baby bearing age that is 15 to 49 years. This ailment otherwise called as Stein-Leventhal Syndrome is described by the structure of cysts on the...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read